Exosens (LSE:0EXO) Research & Development: €0.4 Mil (TTM As of Dec. 2025)


LSE:0EXO Exosens SA LSE:0EXO
46 GF Score
Price €21.00
! 3 Warning Signs
View Full Analysis

What is Exosens Research & Development?

Exosens LSE:0EXO 46 Research & Development is €0.4 Mil as of Dec. 2025. GuruFocus rates LSE:0EXO with a GF Score™ of 46/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Exosens's Research & Development for the six months ended in Dec. 2025 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0.4 Mil.

Exosens  (LSE:0EXO) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Exosens Research & Development Related Terms

Exosens Research & Development Historical Data

* Premium members only.

The historical data trend for Exosens's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Exosens Research & Development Chart

Exosens Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.84 0.66 1.43 1.59 0.00

Exosens Semi-Annual Data
Dec20 Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only 1.08 1.06 0.53 0.43 0.00
LSE:0EXO
46GF Score
Exosens SA LSE:0EXO
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Exosens Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.4 Mil mean?
Exosens (LSE:0EXO) has a Research & Development of €0.4 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Exosens and its competitors.
Is Exosens' Research & Development too high?
Exosens' current Research & Development is €0.4 Mil. Overall, Exosens has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Exosens' Research & Development compare to VRT and BE?
Exosens' Research & Development of €0.4 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Industrial Products company?
A good Research & Development depends on the Industrial Products industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Exosens and its competitors. Exosens's current Research & Development is €0.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Exosens stock overvalued right now?
Exosens (LSE:0EXO) has a current Research & Development of €0.4 Mil. The current Research & Development is €0.4 Mil. Exosens' overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Exosens (LSE:0EXO), the current Research & Development is €0.4 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Exosens Business Description

Address 18 Avenue de Pythagore, Domaine de Pelus, Axis Business Park Bat 5E, Merignac, FRA, 33700
Exosens SA is a high-tech company specializing in electro-optical technologies for amplification, detection, and imaging. It offers products such as night vision tubes, ultraviolet cameras, travelling wave tubes, and various detectors for defense, life sciences, nuclear, and industrial sectors. With multiple production sites in Europe and North America. The company's activities are organized into two main segments: Amplification, which focuses on electron or electromagnetic wave amplification systems mainly used in defense night vision equipment and generates the majority of its revenue, and Detection & Imaging, which provides high value-added components for commercial markets such as nuclear power, research, and industrial applications.
46GF Score

Get the complete analysis for LSE:0EXO

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.00
Price